Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyHighmark Pennsylvania Experimental/Investigational…
    Ask Trek AI about this page
    CurrentHighmark PennsylvaniaPolicy N/A

    Experimental/Investigational Services

    Customize your policy alerts

    Sign up for all Highmark Pennsylvania policy alerts

    Know when Highmark Pennsylvania releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Highmark Pennsylvania's position that specified treatments, procedures, equipment, drugs, services or supplies determined to be experimental or investigational are typically non-covered for commercial members; describes application to professional and facility claims and billing/consent expectations for members.

    Policy Summary
    PayerHighmark Pennsylvania
    PolicyExperimental/Investigational Services
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateMar 21, 2016
    Last ReviewJun 1, 2016
    Next Review DateN/A
    Key ActionApply this policy on a pre-payment basis for both professional and facility claims and deny services deemed experimental/investigational.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    pre-paymentapplied to Professional claims
    pre-paymentapplied to Facility claims
    commercialpolicy position applies to

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    deniedcharges for services listed are

    Coverage Criteria

    Experimental/Investigational Determination

    Charges for services are denied as experimental/investigational when ONE OR MORE of the following reasons apply:

    E/I determination reasons: The intervention does not have FDA approval to be marketed for the specific relevant indication(s);

    Policies apply across professional and facility claims

    E/I determination reasons: Available scientific evidence does not permit conclusions concerning the effect of the intervention on health outcomes;

    Policies apply across professional and facility claims

    E/I determination reasons: The intervention is not proven to be as safe or effective in achieving an outcome equal to or exceeding the outcome of alternative therapies;

    Policies apply across professional and facility claims

    E/I determination reasons: The intervention does not improve health outcomes;

    Policies apply across professional and facility claims

    E/I determination reasons: The intervention is not proven to be applicable outside the research setting.

    Policies apply across professional and facility claims

    This medical policy may not apply to the Federal Employee Program (FEP). Benefits for FEP members are determined by the Federal Employee Program and may differ from the coverage indicated in this policy.

    Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I) and are therefore non-covered. When a service is deemed E/I, a network provider may bill the member only after providing advance written notice, a cost estimate, and obtaining the member's written agreement to assume financial responsibility, with the signed agreement retained in the provider’s records.

    Procedure and Billing Codes

    Procedure codes denied as experimental/investigational (listed in policy)mixedNot Covered
    No codes listed

    Provider Actions and Billing Requirements

    Prior Authorization

    Pre-payment application (professional & facility claims)

    This policy is applied on a pre-payment basis for both professional and facility claims; experimental/investigational services are considered non-covered.

    Note

    Provider-impact summary (commercial lines; limited inpatient exceptions)

    The policy position applies to all commercial lines of business; experimental/investigational services are typically non-covered and may only be eligible in limited inpatient circumstances.

    Documentation Required

    Billing and member consent requirements for E/I services

    Background

    Experimental/Investigational services are interventions—such as a treatment, procedure, facility, equipment, drug, service or supply—that have been determined not to be medically effective for the condition being treated. Charges for services listed on this policy are denied as experimental/investigational when ONE OR MORE of the following apply: the intervention lacks FDA approval for the specific indication; available scientific evidence is insufficient to conclude an effect on health outcomes; the intervention is not proven as safe or effective compared with alternatives; the intervention does not improve health outcomes; or the intervention is applicable only in a research setting.

    Definitions

    Experimental/Investigational Service
    DefinitionA treatment, procedure, facility, equipment, drug, service or supply determined not to be medically effective for the condition being treated.
    Denial triggers (ONE OR MORE)No FDA approval for the specific indication; OR available scientific evidence does not permit conclusions on effect on health outcomes; OR not proven as safe/effective versus alternatives; OR does not improve health outcomes; OR not proven applicable outside research settings.
    Typical coverage stanceServices considered experimental/investigational are typically not covered for commercial lines of business.
    Place of service noteAn experimental/investigational service is typically outpatient only; may be eligible for inpatient coverage in special circumstances (e.g., comorbid condition requiring inpatient monitoring).
    Billing and provider obligationsA network provider billing a member for an E/I service must give advance written notice, provide a cost estimate, obtain the member’s written agreement to assume financial responsibility, and retain the signed agreement in provider records.
    Policy Summary
    PayerHighmark Pennsylvania
    PolicyExperimental/Investigational Services
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateMar 21, 2016
    Last ReviewJun 1, 2016
    Next Review DateN/A
    Key ActionApply this policy on a pre-payment basis for both professional and facility claims and deny services deemed experimental/investigational.
    SourceLink
    On This Page
    Coverage CriteriaProcedure and Billing CodesProvider Actions and Billing RequirementsBackgroundDefinitions

    If a network provider elects to bill a member for an experimental/investigational service, the provider must give advance written notice, provide a cost estimate, obtain the member’s written agreement to assume financial responsibility before the service, and retain the signed agreement in the provider’s records.

    Denial Risk

    Denial triggers for E/I determination

    Charges for services listed in this policy are denied as experimental/investigational when one or more of the listed conditions apply, including lack of FDA approval for the specific indication, insufficient scientific evidence of effect on health outcomes, not proven as safe/effective versus alternatives, failure to improve health outcomes, or applicability only in research settings.

    • Denied when intervention lacks FDA approval for the relevant indication.
    • Denied when available scientific evidence does not permit conclusions about effects on health outcomes.
    • Denied when not proven as safe or effective compared with alternatives.
    • Denied when the intervention does not improve health outcomes.
    • Denied when the intervention is not proven applicable outside research settings.
    Claims handlingPolicy is applied on a pre-payment basis for both professional and facility claims; services deemed E/I are considered non-covered.